Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. Keep ...
Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
The FDA has been rumored to be evaluating whether or not to place a black box warning on vaccines for COVID-19.
The U.S. Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines, ...
A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...
Pfizer (PFE) stock falls, and its COVID vaccine peers such as Moderna (MRNA) and Novavax (NVAX) also drop as the company ...
A team led by Rensselaer Polytechnic Institute (RPI) professors Georges Belfort, Ph.D. (PI), and Pankaj Karande, Ph.D. (co-PI ...
Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...
The US Food and Drug Administration intends to put a “black box” warning on Covid-19 vaccines, according to two people familiar with the agency’s plans.
1don MSN
Moderna receives $54.3M investment for bird flu vaccine, covering axed federal mRNA contracts
Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback